Cann Global Limited (CGB.AX)

0.0210 0.0000 (0.00%) As of 04:37PM AEDT. Market open.

Cann Global Limited

133 Castlereagh Street
Level 21
Sydney, NSW 2000
Australia
61 2 8379 1832
https://www.canngloballimited.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Sholom Dovber Feldman	CEO, MD & Exec. Director	312k	N/A	1976
Mr. Alexander James Neuling ACIS, BSc, FCA (ICAEW), FCIS	Company Sec.	N/A	N/A	1974

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. It operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. The company grows and cultivates hemp and medical cannabis products; provides nutritious and vitamin packed plant-based foods under the Grass Roots brand; and offers skincare products under the Fuss Pot brand. It also engages in the exploration and development of bauxite. The company was formerly known as Queensland Bauxite Limited. Cann Global Limited was incorporated in 2007 and is based in Sydney, Australia.

Corporate governance

Cann Global Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.